Antidepressants - Dr. Watts Flashcards
Clinical features of depression
decreased sleep, appetite changes, fatigue, psychomotor dysfunctions, dysphoric mood, worthlessness, excessive guild, loss of interest/ pleasure in all or most activities
decreased concentration, suicidal ideation
Biogenic amine hypothesis of depression
Reserpine is a small molecule that depletes NE and Seretonin which leads to depression
Found that agents that INCREASE NE and serotonin can treat depression
Neuroendocrine hypothesis of depression
Overactive hypothalamic pituitary adrenal axis and elevated CRF was found in most depressed patients
The over active hypothalamic pituitary adrenal axis may desensitize feedback response in hypothalamus and pituitary
Elevated CRF causes insomnia, anxiety, and decreased appetite and libido
Neurotrophic hypothesis of depression
Brain derived neurotrophic factor (BDNF) is important for neural plasticity, resilience, neurogenesis
BDNF in depressed patients is decreased and we see a decreased volume of hippocampus
BDNF has antidepressant activity and it is shown that antidepressant drugs increase the levels of BDNF and may increase hippocampus volume
Integration of hypotheses of depression
Chronic activation of monoamne receptors leads to increased BDNF signaling and downregulation of the HPA axis
Drug response
There is a delayed clinical response of the drug but it causes an immediate biochemical effect (immediate increase of serotonin)
Its important to mention to patients these drugs take about 3-4 weeks to see full affect
Mechanism of MAOIs
MAOs are found in the presynaptic cleft and they lead to break down of NE and serotonin
MAO inhibitors work by blocking this degradation of norepinephrine and serotonin and thus lead to an increased amount of NE and serotonin in the vesicles that can be released to the synapse causing increased amount in the synapse
Non selective MAO inhibitors
Irreversible
Phenelzine (nardil)
Tranylcypromine (Parnate)
Selective MAO-B inhibitors
Reversible
Selegiline (eldepryl/Ensam)
Safinamide (Xadago)
Selective MAO-A selective
Reversible
Moclobemide (manerix)
MAOi structures
benzo ring with long side chain
MAO inhibitors Side effects and points
Severe side effects : headache, drowsiness, dry mouth, weight gain, ortostatic hypotension, sexual dysfunction
Hypertensive crisis: avoid certain foods and drugs
Interactions with Rx: TCAs, SSRIs, L-Dopa
Avoid foods with Tyramine (partial list): Cheeses, sour cream, sausage, bologna, pepperoni, salami, beer, red wine, avocado, bananas
Targets of reuptake blockers
Target VMAT on the vesicles inside the synapse
Target monoamine transporters (DAT, NET, SERT) located on the plasma membrane and are targets for antidepressant activities
Monoamine transporters (DAT,NET,SERT)
They transport serotonin, norepinephrine, or dopamine along with sodium and chloride (Co-Transporter)
How reuptake inhibitors work
Antidepressants bind at an allosteric site and cause a transformation change that blocks the release of dopamine, serotonin, and norepinephrine into the synapse Leaving more seretonin in the extracellular space
Tricyclic antidepressants
Used for Depression, panic disorder, chronic pain, and enuresis
Overdose/toxicity: extremely dangerous, depressed patients are more likelty to be suicidal
CLASS OF TRICYCLIC ANTIDEPRESSANTS: Tertiary amines MOA, SIDE EFFECTS
MOA: bind allosterically to both NET and SERT to block the reuptake of NE and serotonin and cause an increase of these two in the extracellular space
They also act as receptor antagonists: antihistamine, antimuscarinic, antiadrenergic
Major side effects: these agents cause the mose sedation, autonomic side effects, and weight gain
Another side effrect is conduction disturbances of the heart due to its antagonist activity at alpha 1 receptor
TERTIARY AMINES
Imipramine (tofranil) - active metabolite desipramine (Secondary amine) , enuresis and ADHD
Amitriptyline (elavil): active metabolite nortriptyline ( secondary amine)
Clomipramine (anafranil): used for OCD
Doxepin (Adapin, Sinequan)